Neurovalens CEO Outlines Noninvasive Neuromodulation Plans

from TheBrief.Health · host TheBrief.Health

Neurovalens’ Modius platform brings noninvasive neuromodulation into clinical practice, offering home-based FDA-authorized therapies for insomnia, anxiety, PTSD, and weight management, while facing evidence, reimbursement, and adoption challenges.

Episode metadata supplied by the publisher feed · Published Jun 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Neurovalens CEO Outlines Noninvasive Neuromodulation Plans

0:00 2:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 2 minutes long.

When was this TheBrief.Health episode published?

This episode was published on June 23, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!